Skip to content

Efficacy of block injection of an anti inflammatory medicine in patients with mandibular dental pain

Efficacy of ketorolac and lidocaine inferior alveolar nerve blocks in patients with with symptomatic irreversible pulpitis: a prospective double blind, randomized clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140305016845N7
Enrollment
60
Registered
2018-01-16
Start date
2018-02-14
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symptomatic irreversible pulpits.

Interventions

Intervention 1: Intervention group: 1 mL of Ketrolac Tromethamine solution (30 mg/mL) ( Exir co, Boroojerd, Iran) will be entered to empty carpoul of lidocaine and will be injected at the first IANB s
Treatment - Drugs
Placebo
Intervention group: 1 mL of Ketrolac Tromethamine solution (30 mg/mL) ( Exir co, Boroojerd, Iran) will be entered to empty carpoul of lidocaine and will be injected at the first IANB site as second bl
Control group: In the control group, 5 minutes following the first inferior alveolar nerve block(IANB) using lidocaine, the sham injection will be rendered. So a syringe including 1 mL of lidocaine w

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: patients with age ranged 18-65 without systemic diseases without any medicine consumption 8 h perior root canal treatment symptomatic irreversible pulpitis (HP-Visual Analog Scale(VAS) = 54) in one mandibular molar that needs root canal treatment underestanding of consent form and VAS accepting to participate in research

Exclusion criteria

Exclusion criteria: Patients under 18 and above 65 years old systemic diseases smoking/drug patients pregnant/breast feeding Allergy to NSAID/ anesthetic solutions without a molar tooth no symptomatic irreversible pulpits HP-VAS under 54 Inability to understand data and VAS forms not accepting to participate in the study

Design outcomes

Primary

MeasureTime frame
Pain level during root canal treatment based on HP-VAS 170 mm. Timepoint: Caries and dentin removal, access preparation and root canal preparation stages. Method of measurement: Heft-Parker Visual Analog Scale( HP-VAS) 170 mm.

Secondary

MeasureTime frame
Decreasing the pain level. Timepoint: pain level at caries/dentin removal, access cavity preparation and root canal preparation procedures. Method of measurement: Heft-Parker visual analog scale ( 170 mm).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Mohammadzadeh Akhlaghi

Islamic Azad University

akhlaghinahid@yahoo.com+98 21 2201 1751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026